Cargando…
Retraction Note to: Pharmacological agents in development for diabetic macular edema
Autores principales: | Sadiq, Mohammad Ali, Halim, Muhammad Sohail, Hassan, Muha mmad, Onghanseng, Neil, Karaca, Irmak, Agarwal, Aniruddha, Afridi, Rubbia, Sepah, Yasir J., Do, Diana V., Nguyen, Quan Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720503/ https://www.ncbi.nlm.nih.gov/pubmed/33372631 http://dx.doi.org/10.1186/s40942-020-00271-8 |
Ejemplares similares
-
Evaluation of macular and peripapillary vessel flow density in eyes with no known pathology using optical coherence tomography angiography
por: Hassan, Muhammad, et al.
Publicado: (2017) -
Updates on the Clinical Trials in Diabetic Macular Edema
por: Demirel, Sibel, et al.
Publicado: (2016) -
Diurnal variation of choriocapillaris vessel flow density in normal subjects measured using optical coherence tomography angiography
por: Sarwar, Salman, et al.
Publicado: (2018) -
Topographic correlation between multifocal electroretinography, microperimetry, and spectral-domain optical coherence tomography of the macula in patients with birdshot chorioretinopathy
por: Afridi, Rubbia, et al.
Publicado: (2019) -
Correction of perceived visual distortions using a software application and correlation to age-related macular degeneration
por: Hassan, Muhammad, et al.
Publicado: (2020)